How Much Does Aduhelm Cost?
By
Simon Spichak, MSc
| September 12th, 2022
How much does Aduhelm cost? Even if you can cover the expense, that doesn’t mean the drug is easy to get. Aduhelm costs an…
More Aduhelm Drama: Packaging Could Waste Medicare Millions; Trial Tossed
By
Simon Spichak, MSc
| June 27th, 2022
New findings reveal that the way Aduhelm is packaged leads to wasted medication — and as much as $605 million per year of Medicare…
CMS Says No Aduhelm Coverage for Patients Outside Clinical Trials
By
Simon Spichak, MSc
| April 8th, 2022
The Centers for Medicare and Medicaid Services finalized its decision to limit the coverage of Alzheimer’s drug Aduhelm and future monoclonal antibodies. In February…
Biogen Slashes Aduhelm Price; EMA Rejects It in EU
By
Simon Spichak, MSc
| December 20th, 2021
European drug regulators dealt a blow to Biogen, deciding against allowing Aduhelm onto the market. Meanwhile, the company slashed the price of its drug…
Phil’s Journal: Aduhelm Is Greenlit to Treat Alzheimer’s—It’s Still Complicated
By
Phil Gutis
| June 9th, 2021
As an aducanumab trial participant, Phil Gutis, a reporter with early-stage Alzheimer’s, was part of Aduhelm’s journey to FDA approval. Doctors can soon start…
Aducanumab Approved: U.S. FDA Gives Biogen Alzheimer’s Drug Approval
By
Phil Gutis
| June 7th, 2021
“Historic moment:” Today, the FDA gave Biogen’s investigational Alzheimer’s drug aducanumab its approval, with the requirement that they conduct a post-approval trial. In a…
Alzheimer’s Association All In On Not-Yet-Approved Aducanumab
By
Phil Gutis
| May 6th, 2021
“It’s Time for More Time” With the #MoreTime campaign, the Alzheimer’s Association has gone all in on aducanumab, the controversial new Alzheimer’s drug produced…